We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Copan Expands US Manufacturing Operations with Multimillion Dollar Investment

By LabMedica International staff writers
Posted on 03 Sep 2009
Copan Diagnostics, Inc. More...
(Murrieta, CA, USA) is undertaking a new multimillion US dollar investment project to bring plastic transfer pipette and additional medical device manufacturing operations to its California, USA facility.

Plastic transfer pipettes are essential products widely used by hospital and other laboratories for transferring liquids and clinical samples during diagnostics testing or analytical research. As many as 500 million pipettes are used in the United States annually. Copan developed a customized blow molding equipment that maximizes productivity through a fully automated system for separating the molded product from waste material, which is then 100% recycled.

A 1208 m2 building adjacent to its current facility was purchased by Copan to house new plastic blow molding equipment that is used to manufacture transfer pipettes. The new building allows the transfer of some activities from its current location, thus allowing more space for Copan to expand medical device manufacturing operations for the company's microbiology specimen collection and transport line.

The project is an integral part of Copan's plan to support future demand. Norman Sharples, executive vice president at Copan Diagnostics, said, "in today's market, companies must examine opportunities to bring further efficiencies to their operations to remain competitive, which is what we are doing with this endeavor."

Copan Diagnostics manufactures collection and transport systems and offers a complete range of microbial sampling products for traditional culture analysis and molecular diagnostic assays. The company also produces flocked swabs, universal transport medium, the ESwab and other laboratory consumables. The Walk-Away Specimen Processor (WASP), a system for automatic planting and streaking of microbiology samples, is another Copan product.

Related Links:
Copan Diagnostics, Inc.




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.